drugset / Trial / NCT05285566

Pain Control for Undergoing Costal Cartilage Harvesting

NCT05285566 ↗

Phase 4 Recruiting 60 enrolled Mayo Clinic
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to find out whether injecting the U.S. Food and Drug Administration (FDA) approved drug EXPAREL®, a long acting (approximately 96 hours) numbing medication, will reduce pain after rib cartilage removal in comparison to the standard injection of XYLOCAINE®.

Timeline

Start
2022-05-04
Primary completion
2026-08
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 106 mg Subcutaneous
Comparator Lidocaine Other / unclassified 8 ml —

Indications